GWAS locates gene variants protective against ribavirin-induced hemolytic anemia in chronic hepatitis C patients

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:521 / 521
页数:1
相关论文
共 50 条
  • [21] Ribavirin-induced anemia: Incidence and impact to treatment response of chronic hepatitis C
    Leerapun, Apinya
    Soontornpun, Atiwat
    Pisespongsa, Pises
    Chitapanarux, Taned
    Kijdamrongthum, Phuripong
    Thongsawat, Satawat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 267 - 267
  • [22] Ribavirin-Induced Anemia is Affected by Renal Function in Elderly Chronic Hepatitis C(CHC)Patients
    Spinzi, Giancarlo
    Borroni, Gianmario
    Andreoletti, Marco
    Bortoli, Aurora
    Casiraghi, Mariaantonietta
    Cazzaniga, Massimo
    Ceriani, Roberto
    Guerzoni, Patrizia
    Pich, Maria Gioia
    Prada, Alberto
    Omazzi, Barbara
    Terreni, Natalia M.
    GASTROENTEROLOGY, 2011, 140 (05) : S949 - S949
  • [23] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Kurashige, Nao
    Tsuda, Natsuko
    Yakushijin, Takayuki
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Kato, Michio
    Yoshihara, Harumasa
    Katayama, Kazuhiro
    Kubota, Shinji
    Hijioka, Taizo
    Ishibashi, Kazunobu
    Oshita, Masahide
    Hagiwara, Hideki
    Haruna, Yoshimichi
    Mita, Eiji
    Tamura, Shinji
    Hayashi, Norio
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (09) : 862 - 872
  • [24] An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C
    Chen, Sheng-Hung
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Li, Yu-Fen
    Chuang, Po-Heng
    Chen, Ching-Hsiang
    HEPATITIS MONTHLY, 2015, 15 (03)
  • [25] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
    Tsugiko Oze
    Naoki Hiramatsu
    Nao Kurashige
    Natsuko Tsuda
    Takayuki Yakushijin
    Tatsuya Kanto
    Tetsuo Takehara
    Akinori Kasahara
    Michio Kato
    Harumasa Yoshihara
    Kazuhiro Katayama
    Shinji Kubota
    Taizo Hijioka
    Kazunobu Ishibashi
    Masahide Oshita
    Hideki Hagiwara
    Yoshimichi Haruna
    Eiji Mita
    Shinji Tamura
    Norio Hayashi
    Journal of Gastroenterology, 2006, 41 : 862 - 872
  • [26] Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination Therapy
    Krishnan, Sheeja M.
    Dixit, Narendra M.
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (02)
  • [27] ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C
    El Raziky, Maissa
    Zayed, Naglaa A.
    Baki, Amin Abdel
    Mansour, Shimaa A.
    Shahin, Rasha M. H.
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (10) : 1823 - 1829
  • [28] Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C
    Akihito Tsubota
    Noritomo Shimada
    Hiroshi Abe
    Kai Yoshizawa
    Rie Agata
    Yoko Yumoto
    Makiko Ika
    Yoshihisa Namiki
    Keisuke Nagatsuma
    Hiroshi Matsudaira
    Kiyotaka Fujise
    Norio Tada
    Yoshio Aizawa
    World Journal of Gastroenterology, 2012, (41) : 5879 - 5888
  • [29] Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Yoshizawa, Kai
    Agata, Rie
    Yumoto, Yoko
    Ika, Makiko
    Namiki, Yoshihisa
    Nagatsuma, Keisuke
    Matsudaira, Hiroshi
    Fujise, Kiyotaka
    Tada, Norio
    Aizawa, Yoshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (41) : 5879 - 5888
  • [30] Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia
    Mangoni, ED
    Marrone, A
    Saviano, D
    Del Vecchio, C
    Utili, R
    Ruggiero, G
    ANTIVIRAL THERAPY, 2003, 8 (01) : 57 - 63